Regions Financial Corp Caladrius Biosciences, Inc. Transaction History

Regions Financial Corp

  • $13.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 19, 2019
SELL
$2.25 - $3.6 $5,028 - $8,046
-2,235 Closed
0 $0
Q3 2018

Oct 22, 2018
BUY
$4.85 - $6.5 $169 - $227
35 Added 1.59%
2,235 $13,000
Q4 2017

Jan 18, 2018
BUY
$2.66 - $3.71 $5,852 - $8,162
2,200
2,200 $8,000

About CALADRIUS BIOSCIENCES, INC.

CLBS Quotes by TradingView
  • Ticker CLBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,583,200
  • Market Cap $25.8M
  • Description
  • Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...
More about CLBS
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email